Sell Ranbaxy, says Sudarshan Sukhani

Sell Ranbaxy, says Sudarshan Sukhani of s2analytics.com.

Sukhani told CNBC-TV18, "I would sell Ranbaxy. I do not see it holding even Rs 400. For a short term trader Rs 425 is a possible target on the downside but I doubt if Rs 400 will hold."
He further added, "Arvind was consolidating for the last two weeks after that big decline from Rs 100-107 and that consolidation usually appears midway in decline. The final targets for Arvind are Rs 60. Now intraday short term targets will be much more modest but the trade here is to sell on every rally, sell on break-downs because we are going much lower."